BioXcel Therapeutics Ownership | Who Owns BioXcel Therapeutics?
BioXcel Therapeutics Ownership Summary
BioXcel Therapeutics is owned by 7.01% institutional investors, 4.21% insiders, and 88.78% retail investors. Oaktree capital management lp is the largest institutional shareholder, holding 3.08% of BTAI shares. BSO Bio Santé C is the top mutual fund, with 2.26% of its assets in BioXcel Therapeutics shares.
BTAI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioXcel Therapeutics | 7.01% | 4.21% | 88.78% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Oaktree capital management lp | 241.19K | 3.08% | $617.44K |
| Fmr | 198.60K | 2.53% | $508.42K |
| Vanguard group | 192.13K | 2.45% | $491.84K |
| Geode capital management | 125.24K | 1.60% | $320.62K |
| Xtx topco | 113.36K | 1.45% | $290.21K |
| Blackrock | 440.69K | 1.43% | $564.08K |
| Blackrock funding, inc. /de | 84.28K | 1.07% | $215.76K |
| State street | 52.72K | 0.67% | $134.96K |
| Charles schwab investment management | 203.62K | 0.66% | $260.63K |
| Ubs group | 43.54K | 0.56% | $111.47K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Oaktree fund advisors | 42.91K | 0.20% | $109.86K |
| Slt | 29.50K | 0.05% | $75.52K |
| Xtx topco | 113.36K | 0.02% | $290.21K |
| Oaktree capital management lp | 241.19K | 0.01% | $617.44K |
| Diversify wealth management | 15.00K | 0.00% | $28.50K |
| Foundations investment advisors | 29.55K | 0.00% | $75.64K |
| Tower research capital llc (trc) | 3.93K | 0.00% | $10.07K |
| Allsquare wealth management | 175.00 | 0.00% | $317.00 |
| Jones financial companies lllp | 36.00K | 0.00% | $97.20K |
| Hightower advisors | 35.00K | 0.00% | $89.60K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 198.60K | - | 198.60K |
| Vanguard group | 192.13K | - | 173.30K |
| Geode capital management | 125.24K | - | 97.06K |
| Xtx topco | 113.36K | 0.02% | 89.94K |
| Goldman sachs group | 98.97K | - | 76.20K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -4.32M |
| Blackrock | 440.69K | - | -887.38K |
| Ameriprise financial | - | - | -579.16K |
| Bank of new york mellon | - | - | -123.08K |
| Millennium management | - | - | -104.97K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| State street | 52.72K | - | 52.72K | $134.96K |
| Northern trust | 37.73K | - | 37.73K | $96.60K |
| Foundations investment advisors | 29.55K | 0.00% | 29.55K | $75.64K |
| Slt | 29.50K | 0.05% | 29.50K | $75.52K |
| Aqr capital management | 14.36K | - | 14.36K | $18.38K |
Sold Out
| Holder | Change |
|---|---|
| Mount yale investment advisors | -1.00 |
| Federation des caisses desjardins du quebec | -1.00 |
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Farther finance advisors | -5.00 |
| National bank of canada /fi/ | -6.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 16 | -51.52% | 549,847 | -11.04% | 7 | 11.29% | 10 | -33.33% | 1 | -85.71% |
| Jun 30, 2025 | 32 | 3.23% | 613,025 | 61.47% | 7 | 797.16% | 14 | 100.00% | 7 | -70.83% |
| Mar 31, 2025 | 1 | -97.92% | 661 | -99.99% | - | 0.85% | 1 | -94.74% | - | -100.00% |
| Dec 31, 2024 | 13 | -74.00% | 537,273 | -82.68% | 1 | 2.37% | 4 | -63.64% | 6 | -77.78% |
| Sep 30, 2024 | 50 | -33.33% | 3,102,869 | -68.25% | 7 | 0.73% | 12 | -72.73% | 27 | 50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BSO Bio Santé C | 70.00K | 2.26% | - |
| Vanguard Total Stock Mkt Idx Inv | 55.39K | 1.73% | - |
| Fidelity Growth Compy Commingled Pl O | 469.48K | 1.15% | -425.27K |
| Vanguard US Total Market Shares ETF | 886.24K | 1.01% | -1.00 |
| Fidelity Growth Company Fund | 353.64K | 0.87% | -248.67K |
| Vanguard Institutional Extnd Mkt Idx Tr | 43.45K | 0.66% | 25.12K |
| Fidelity Growth Company K6 | 163.94K | 0.40% | -132.22K |
| Fidelity Series Growth Company | 88.26K | 0.22% | -63.60K |
| Fidelity Extended Market Index | 27.57K | 0.17% | 13.34K |
| NT R2000 Growth Index Fund - NL | 57.60K | 0.14% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 16, 2024 | O'Neill Vincent | See Remarks | Sell | $58.13 |
| Dec 16, 2024 | Mehta Vimal | CEO and President | Sell | $773.36 |
| Dec 16, 2024 | Mehta Vimal | CEO and President | Sell | $357.91 |
| Dec 16, 2024 | Steinhart Richard I | Chief Financial Officer | Sell | $73.80 |
| Dec 16, 2024 | Steinhart Richard I | Chief Financial Officer | Sell | $133.18 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 12 |
BTAI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools